Drug Trial Radar · NCT05143996
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
275
Planned (sponsor's estimate)
Start
Nov 18, 2021
Primary completion
Dec 30, 2029
Study completion Dec 30, 2029
Sponsor
- Lead sponsor
- Cullinan Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 3, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
CLN-049-001 is a Phase 1/2, open-label, multicenter, first-in-human trial of CLN-049 in patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Conditions
- Relapsed/Refractory Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- TP53-mutated MDS and AML
Interventions
CLN-049Drug
\[FLT3\] x \[CD3\] bispecific T cell engager
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of treatment emergent events (TEAEs)Time frame: 28 days
- Cmax of CLN-049Time frame: Up to 13 weeks
- Ctrough of CLN-049Time frame: 28 Days
- Tmax of CLN-049Time frame: 28 Days
- T1/2 of CLN-049Time frame: Up to 28 days
- Efficacy of CLN-049Time frame: Up to 13 weeks
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama O'Neal Cancer Center
Birmingham, Alabama · Recruiting
Mayo Clinic Hospital - Phoenix
Phoenix, Arizona · Not yet recruiting
City of Hope
Duarte, California · Not yet recruiting
UCLA
Los Angeles, California · Recruiting
UCHealth Anschutz Cancer Pavilion
Aurora, Colorado · Not yet recruiting
Mayo Clinic Hospital - Jacksonville
Jacksonville, Florida · Not yet recruiting
University of Miami Health System
Miami, Florida · Recruiting
Moffitt Cancer Center
Tampa, Florida · Recruiting
Emory University Hospital
Atlanta, Georgia · Recruiting
Massachusetts General Hospital
Boston, Massachusetts · Completed
Mayo Clinic Hospital - Rochester
Rochester, Minnesota · Not yet recruiting
Roswell Park Cancer Institute
Buffalo, New York · Recruiting
New York University
New York, New York · Recruiting
New York-Presbyterian / Weill Cornell Medical Center
New York, New York · Not yet recruiting
Duke Cancer Center
Durham, North Carolina · Recruiting
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio · Withdrawn
MD Anderson
Houston, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.